Veritaz HealthCare Limited was incorporated and established in October 2005 by visionary Mr. Sarath Chandra Reddy and few other like-minded professionals by acquiring brands from our erstwhile company, Citadel Aurobindo Biotech Limited. Since then, there has been no looking back for Veritaz. We are one of the leading pharmaceutical companies in India with over a decade of experience in providing healthcare products with the aim of improving human life.
Our Vision: Our vision is to be the most admired organization for employees and customers in the Indian Pharma market while delivering the highest standards of performance.
To bring new molecules to the market that will help the overall community to live a healthier & happier life. Our aim is to provide our customers with latest trends and references to make a rational choice in the treatment of diseases leading to customer delight.
Our Mission: Our mission is to become Rs.500 crore company in Indian Pharma market and to create a resonating customer experience ensuring customer delight at every stage. We are currently engaged in building our arrow-head brands to achieve segment leadership. We are aiming to create a niche segment by launching differentiated products to achieve market beating growth and create resilient revenue.
We are striving to place ourselves on a strong path by expanding our business strategically, strengthening and enhancing capabilities across the organization. We constantly partner with healthcare professionals to provide superior quality of life to patients. We are looking at various opportunities to reach customers in untapped markets, to provide our products, by associating with business partners.
Our Guiding Policies are to:
- Have World-class quality products at affordable prices
- Do continuous Research & Development to innovate & provide better Medicare products
- Bring improvement in process and people
- Be a competent professional organization
- Have sound customer oriented marketing & distribution
- Have ethical business practices
We have a presence in key therapeutic segments such as Antibacterial, Antipyretic & Analgesic, Anti-inflammatory, Decongestants, Nutritionals, Antacids & PPIs, High-end parenteral antibiotics and other hospital related products.
Our Derma division has successfully forayed into Dermatology segment with Cosmetics & Derma Products We further aim to strengthen our presence in the above segments by introducing new and improved molecules with dosage forms.
Our Veritaz division has a legacy of brands like Fepanil, Lysatone, Delcon & Acinil that have been successful for decades. Fepanil group is ranked 6th & Fepanil Suspension is ranked 4th in the Paracetamol category. Lysatone Plus & Delcon ranks amongst the top 5 brands in their respective markets.
We have tied-up with ‘Viridis Biopharma’ to launch “Verispore” our brand of Bacillus subtilis (HU58™) which will be available to extend benefits to patients from July’17. Viridis Biopharma, is a multifaceted company, deeply involved in scientific research, is connected to some of the world’s leading research-based healthcare and personal care companies. Its in-licensing agreement with Royal Holloway (acknowledged for its research excellence world over) provides us an opportunity to launch ‘Verispore’.
Our Hospin division has the expertise of supplying lifesaving antibiotics to eminent hospitals across the country. Derma division majorly focuses on Acne, Hair Care, Depigmentation Products & Sunscreen Lotions.
The Future Ahead
Veritaz is now poised for a new phase of growth. To meet the challenges of the future, it has drawn up fresh strategies and planned new forays. With a strong base in Pediatric range, we aim to enter niche segments like Pediatric Neurology, Neo Natal Intensive Care. We have developed our capabilities to explore & utilize digital media to further strengthen our connect with healthcare professionals & patients. We are now geared to meet the emerging trends and challenges of the Indian Pharma Market.